Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion type Assertion NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_head.
- NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion description "[In addition, it was also significantly associated with the loss of estrogen receptor (ER) and progesterone receptor (PR), the prognostic markers of the breast cancer (P < 0.05), while not with HER2, tumor size, and lymph node metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_provenance.
- NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion evidence source_evidence_literature NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_provenance.
- NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion SIO_000772 22699783 NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_provenance.
- NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion wasDerivedFrom befree-2016 NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_provenance.
- NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_assertion wasGeneratedBy ECO_0000203 NP990231.RAP2Fyw5T5IN3ImT7Vc1IFSX45OGxgA7RZ6OoMB9q1XO0130_provenance.